CELLPRO CEPRATE SC BONE MARROW STEM CELL CONCENTRATION SYSTEM GAINS FDA APPROVAL DEC. 6; FIRM LAUNCHES SYSTEM AT AMERICAN SOCIETY OF HEMATOLOGY
This article was originally published in The Gray Sheet
Executive Summary
CellPro has begun shipping its Ceprate SC stem cell concentration system at a price of $24,985 following FDA approval Dec. 6 of a premarket approval application for the device. The approval is FDA's first for a system to purify stem cells for bone marrow transplantation.